Stress Management for High Blood Pressure

NCT ID: NCT02371317

Last Updated: 2019-08-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

141 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-05-01

Study Completion Date

2020-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to examine the efficacy of two stress management interventions in reducing blood pressure (BP) in patients who have prehypertension (BP between 120/80 and 139/89). It is expected that participants will be better able to control their BP through reducing stress and increasing healthy lifestyle behaviors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prehypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mindfulness-Based Stress Reduction

The Mindfulness-Based Stress Reduction intervention includes eight 2.5-hour weekly group sessions and an all-day retreat.

Group Type EXPERIMENTAL

Mindfulness-Based Stress Reduction

Intervention Type BEHAVIORAL

Patients are randomized to an intervention

American Heart Association Recommended Self-Care

Intervention Type OTHER

All Patients receive AHA Recommended Self-Care

Stress Management Education

The Stress Management Education intervention includes eight 2.5-hour weekly group sessions and an all-day retreat.

Group Type ACTIVE_COMPARATOR

Stress Management Education

Intervention Type BEHAVIORAL

Patients are randomized to an intervention

American Heart Association Recommended Self-Care

Intervention Type OTHER

All Patients receive AHA Recommended Self-Care

AHA Recommended Self-Care

All participants will receive the American Heart Association - Understanding and Controlling Your High Blood Pressure Brochure and information on the Dietary Approach to Stop Hypertension from the National Institutes of Health. These brochures describe ways that individuals can improve their lifestyle through better diet and exercise. Participants will get a chance to try and make healthy lifestyle changes on their own, using this information.

Group Type OTHER

American Heart Association Recommended Self-Care

Intervention Type OTHER

All Patients receive AHA Recommended Self-Care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mindfulness-Based Stress Reduction

Patients are randomized to an intervention

Intervention Type BEHAVIORAL

Stress Management Education

Patients are randomized to an intervention

Intervention Type BEHAVIORAL

American Heart Association Recommended Self-Care

All Patients receive AHA Recommended Self-Care

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MBSR SME

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Unmedicated high blood pressure (SBP of 120-139 or DBP of 80-89)
* BMI in the range of 19-40
* Interest in attempting to control blood pressure through lifestyle modification

Exclusion Criteria

* pacemakers
* uncontrolled hypertension (SBP≥140 or DBP≥90)
* atrial fibrillation
* myocardial infarction (MI)
* percutaneous transluminal coronary angioplasty (PTCA)
* coronary artery bypass graft (CABG) within 6 months of enrollment
* congestive heart failure
* uncorrected primary valvular disease hypertrophic or restrictive cardiomyopathy
* uncorrected thyroid heart disease
* chronic kidney disease
* persistent tachyarrhythmia
* JNC risk category C (target organ damage, diabetes)
* patients who are pregnant or plan to become pregnant within 9 months
* patients who are lactating
* patients unable to comply with assessment procedures
* patients with alcohol or drug abuse within 12 months
* patients who consume more than 21 alcoholic drinks per week
* patients who are current smokers
* patients who are unable to provide informed consent or who have dementia
* patients with previous extensive meditation or yoga training
* patients with blood pressure ≥140/90
Minimum Eligible Age

21 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Pennsylvania

OTHER

Sponsor Role collaborator

Case Western Reserve University

OTHER

Sponsor Role collaborator

Kent State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

David M. Fresco

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David M Fresco, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Kent State University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

W.O. Walker Building

Cleveland, Ohio, United States

Site Status

University of Pennsylvania Perelman School of Medicine

Philadelphia, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Hughes JW, Fresco DM, Myerscough R, van Dulmen MH, Carlson LE, Josephson R. Randomized controlled trial of mindfulness-based stress reduction for prehypertension. Psychosom Med. 2013 Oct;75(8):721-8. doi: 10.1097/PSY.0b013e3182a3e4e5.

Reference Type BACKGROUND
PMID: 24127622 (View on PubMed)

Chin GR, Greeson JM, Hughes JW, Fresco DM. Does Dispositional Mindfulness Predict Cardiovascular Reactivity to Emotional Stress in Prehypertension? Latent Growth Curve Analyses from the Serenity Study. Mindfulness (N Y). 2021 Nov;12(11):2624-2634. doi: 10.1007/s12671-021-01745-y. Epub 2021 Sep 18.

Reference Type DERIVED
PMID: 35694435 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KentSU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mindfulness & Mechanisms Study
NCT04626245 ACTIVE_NOT_RECRUITING NA
Behavioral Study to Control Blood Pressure
NCT01035554 COMPLETED PHASE2/PHASE3